Cognitive and psychiatric disturbances in Parkinson?s disease

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00055890" target="_blank" >RIV/00216224:14110/11:00055890 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.2217/ahe.11.3" target="_blank" >http://dx.doi.org/10.2217/ahe.11.3</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.2217/ahe.11.3" target="_blank" >10.2217/ahe.11.3</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Cognitive and psychiatric disturbances in Parkinson?s disease

Popis výsledku v původním jazyce

Psychiatric symptoms and cognitive impairment occur in the majority of patients with Parkinson?s disease and have important clinical consequences for the patient and caregivers, in addition to healthrelated costs. Dysphoria and anxiety, hallucinations, apathy and cognitive impairment are the most common symptoms. The etiology is heterogeneous and includes psychosocial, structural and chemical brain changes, and treatment-related factors. Consensus criteria for the diagnoses of psychosis, depression anddementia associated with Parkinson?s disease are now available, and a number of rating scales and questionnaires have been validated for the evaluation of cognitive impairment and psychiatric symptoms in Parkinson?s disease. Level I evidence is availablefor the treatment of dementia, depression and psychosis, but there is still a need for development of safer and more effective treatments.

Název v anglickém jazyce

Cognitive and psychiatric disturbances in Parkinson?s disease

Popis výsledku anglicky

Psychiatric symptoms and cognitive impairment occur in the majority of patients with Parkinson?s disease and have important clinical consequences for the patient and caregivers, in addition to healthrelated costs. Dysphoria and anxiety, hallucinations, apathy and cognitive impairment are the most common symptoms. The etiology is heterogeneous and includes psychosocial, structural and chemical brain changes, and treatment-related factors. Consensus criteria for the diagnoses of psychosis, depression anddementia associated with Parkinson?s disease are now available, and a number of rating scales and questionnaires have been validated for the evaluation of cognitive impairment and psychiatric symptoms in Parkinson?s disease. Level I evidence is availablefor the treatment of dementia, depression and psychosis, but there is still a need for development of safer and more effective treatments.

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FH - Neurologie, neurochirurgie, neurovědy

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2011

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Aging Health

ISSN

1745-509X

e-ISSN

—

Svazek periodika

7

Číslo periodika v rámci svazku

1

Stát vydavatele periodika

NO - Norské království

Počet stran výsledku

20

Strana od-do

123-142

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—